stock
NKTR · NEKTAR THERAPEUTICS
What NEKTAR THERAPEUTICS reports to the SEC, read from its filings.
Open in the appPrice
The live NKTR price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on NKTR.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 34,142,994 as of 2026-08-07 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- -257.8%
- Net
- -287.7%
Returns
- ROE
- -17.4%
- ROA
- -14.3%
Health
- Current ratio
- 10.4x
- Debt/equity
- —
Deep value
- NCAV
- $547.39M
- NCAV per share
- $16.03
- Price/NCAV
- Locked
- NNWC
- -$152.74M
- NNWC per share
- -$4.47
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $10.13M | — | -$42.34M | -$40.62M | 10-Q filed 2026-08-14 |
| 2026-03-31 | $10.86M | — | -$39.05M | -$44.90M | 10-Q filed 2026-05-08 |
| 2025-12-31 | $21.81M | — | -$27.66M | -$36.00M | DEF 14A filed 2026-04-24 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | $11.79M | — | -$31.67M | -$35.52M | 10-Q filed 2025-11-07 |
| 2025-06-30 | $11.18M | — | -$36.23M | -$41.59M | 10-Q filed 2026-08-14 |
| 2025-03-31 | $10.46M | — | -$44.53M | -$50.88M | 10-Q filed 2026-05-08 |
| 2024-12-31 | $29.18M | — | $14.35M | $7.22M | DEF 14A filed 2026-04-24 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-09-30 | $24.12M | — | -$34.34M | -$37.06M | 10-Q filed 2025-11-07 |
- Assets
- $1.10B
- Equity
- $903.12M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $55.23M | -$140.10M | -$164.00M | -$208.68M |
| 2024-12-31 | $98.43M | -$105.20M | -$119.00M | -$177.18M |
| 2023-12-31 | $90.12M | -$263.68M | -$276.00M | -$193.47M |
| 2022-12-31 | $92.06M | -$376.17M | -$368.00M | -$309.68M |
| 2021-12-31 | $101.91M | -$446.10M | -$524.00M | -$427.65M |
| 2020-12-31 | $152.91M | -$425.11M | -$444.44M | -$320.55M |
| 2019-12-31 | $114.62M | -$440.04M | -$440.67M | -$354.97M |
| 2018-12-31 | $1.19B | $687.93M | $681.31M | $703.98M |
| 2017-12-31 | $307.71M | -$59.64M | -$96.69M | -$90.09M |
| 2016-12-31 | $165.44M | -$112.86M | -$153.52M | -$123.42M |
Company filings
since Wed Nov 12 · 6 offering filings in 12 months · since Fri May 8
events
Regulation FD disclosure
Regulation FD disclosureOct 18-KOther event
Other eventSep 258-KRegulation FD disclosure
Regulation FD disclosureSep 88-KResults
ResultsAug 138-KShareholder vote results
Shareholder vote resultsJun 58-KMaterial agreement, Executive or director change
Material agreementExecutive or director changeMay 88-K
5% owners ()
Two Seas Capital LP
Stake update
Two Seas Capital LP
Stake update
BIOTECHNOLOGY VALUE FUND L P
Stake update
Vanguard Capital Management
Passive stake
BlackRock, Inc.
Passive stake
Insiders, politicians and funds
Insider trades, last 90 days
Zalevsky Jonathan
Chief R&D Officer
Sale$13,388Aug 20, 7:05 PM ET
ROBIN HOWARD W
President & CEO, Director
Sale$30,088Aug 20, 7:03 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
None of the tracked funds held this at their last 13F.
News
Stories that named NKTR, and the market events around them.
Sign in to see thisBoard
Recent signals
Signals open up here once a member has posted about NKTR.
Signals are informational.
Posts · 0
No posts yet.
nakagai
Signals on NKTR come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the NKTR board